Literature DB >> 29471630

Ir(III)/MPAA-Catalyzed Mild and Selective C-H Amidation of N-Sulfonyl Ketimines: Access To Benzosultam-Fused Quinazolines/Quinazolinones.

Aniket Mishra1, Upasana Mukherjee1, Tripta Kumari Vats1, Indubhusan Deb1.   

Abstract

Ir(III)-catalyzed unprecedented mild C-H amidation for weakly coordinating cyclic N-sulfonyl ketimines, accelerated by a mono protected l-amino acid, has been developed. The method uses 1,4,2-dioxazol-5-ones as the robust amidating reagent in conjunction with a catalytic amount of silver triflate. It is highly selective and does not require a stoichiometric amount of oxidants or additives. A series of mechanistic experiments was performed to gain some insights into the reaction mechanism. The strategy provides easy access to novel benzosultam-quinazoline and benzosultam-quinazolinone hybrid scaffolds endowed with pharmaceutically relevant features.

Entities:  

Year:  2018        PMID: 29471630     DOI: 10.1021/acs.joc.8b00125

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Synthesis of Azolo[1,3,5]triazines via Rhodium(III)-Catalyzed Annulation of N-Azolo Imines and Dioxazolones.

Authors:  Gia L Hoang; Kim Søholm Halskov; Jonathan A Ellman
Journal:  J Org Chem       Date:  2018-06-27       Impact factor: 4.354

2.  Basicity-Tuned Reactivity: diaza-[1,2]-Wittig versus diaza-[1,3]-Wittig Rearrangements of 3,4-Dihydro-2H-1,2,3-benzothiadiazine 1,1-Dioxides.

Authors:  Imre Gyűjtő; Márta Porcs-Makkay; Gergő Szabó; Zsolt Kelemen; Gyöngyvér Pusztai; Gábor Tóth; András Dancsó; Judit Halász; Gyula Simig; Balázs Volk; László Nyulászi
Journal:  J Org Chem       Date:  2020-12-31       Impact factor: 4.354

3.  Copper-catalyzed domino sequences: a new route to pyrido-fused quinazolinones from 2'-haloacetophenones and 2-aminopyridines.

Authors:  Phuc H Pham; Son H Doan; Ngan T H Vuong; Vu H H Nguyen; Phuong T M Ha; Nam T S Phan
Journal:  RSC Adv       Date:  2018-06-04       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.